Stock FLERIE FLERIE INVEST AB
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Flerie Invest AB

Equities

FLERIE

SE0008966295

Market Closed - Nasdaq Stockholm
Other stock markets
 17:00:00 28/06/2024 BST 		5-day change 1st Jan Change
0.472 SEK -1.67% Intraday chart for Flerie Invest AB -5.41% +84.38%
06-28 Flerie AB(OM:FLERIE) added to OMX Nordic All-Share Index CI
06-14 Alligator Bioscience Names New CFO MT

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Alligator Bioscience Names New CFO
Flerie Invest AB completed the acquisition of InDex Pharmaceuticals Holding AB (OM:INDEX) from group of shareholders.
InDex Pharmaceuticals Gets OK to Keep Nasdaq First North Growth Market Listing Amid Reverse Takeover, Uplisting Plans
En Direct des Marchés : Sanofi, Airbus, Rubis, Atos, Valneva, Microsoft, Tesla, Generali...
La Tech en orbite
Borsa di Italia: tecnologia in orbita
Bolsa de Madrid: Tecnología en órbita
InDex Pharmaceuticals to Buy Flerie Invest Under Reverse Merger Plan
InDex Pharmaceuticals Holding AB Approves the Election of Karl Tobieson as Board Member
InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Index Pharmaceuticals Holding AB Announces Board Resignations
InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease
Index Pharmaceuticals Holding AB Announces Resignation of Johan Giléus as Deputy CEO
InDex Pharmaceuticals Holding AB Announces Resignation of Jenny Sundqvist as CEO, Effective September 26, 2024
InDex Pharmaceuticals Launches Strategic Review Amid Decision to Stop Cobitolimod Development
InDex Pharmaceuticals Holding AB Discontinues the Development of Cobitolimod
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
InDex Pharmaceuticals Holding AB Discontinues Cobitolimod Phase III Program
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FLERIE Stock
  4. News Flerie Invest AB
  5. Other languages